Byam Rebecca 4
4 · HCW Biologics Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Byam Rebecca
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-20$1.40/sh+760,714$1,065,000→ 1,381,909 total
Footnotes (1)
- [F1]The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.